Cell Biotech Co. Ltd (049960) - Total Liabilities

Latest as of September 2025: ₩7.46 Billion KRW ≈ $5.06 Million USD

Based on the latest financial reports, Cell Biotech Co. Ltd (049960) has total liabilities worth ₩7.46 Billion KRW (≈ $5.06 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Cell Biotech Co. Ltd (049960) equity growth momentum to track the company's year-over-year net asset growth rate.

Cell Biotech Co. Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how Cell Biotech Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 049960 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Cell Biotech Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Cell Biotech Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Industri Dan Perdagangan Bintraco Dharma Tbk PT JK:CARS	Indonesia	Rp2.10 Trillion
Orbitech Co. Ltd KQ:046120	Korea	₩56.53 Billion
Gabriel Holding CO:GABR	Denmark	Dkr442.64 Million
Nordic Mining ASA OL:NOM	Norway	Nkr2.32 Billion
Exicon Co. Ltd KQ:092870	Korea	₩35.14 Billion
Fifth District Bancorp, Inc. Common Stock NASDAQ:FDSB	USA	$404.64 Million
Champions Oncology Inc NASDAQ:CSBR	USA	$24.07 Million
Quantum Graphite Ltd AU:QGL	Australia	AU$10.23 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Cell Biotech Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Cell Biotech Co. Ltd (049960) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	13.72	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cell Biotech Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cell Biotech Co. Ltd (2011–2024)

The table below shows the annual total liabilities of Cell Biotech Co. Ltd from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩6.23 Billion ≈ $4.22 Million	+8.23%
2023-12-31	₩5.76 Billion ≈ $3.90 Million	-25.70%
2022-12-31	₩7.75 Billion ≈ $5.25 Million	+25.16%
2021-12-31	₩6.19 Billion ≈ $4.19 Million	+16.42%
2020-12-31	₩5.32 Billion ≈ $3.60 Million	+13.09%
2019-12-31	₩4.70 Billion ≈ $3.19 Million	-26.80%
2018-12-31	₩6.42 Billion ≈ $4.35 Million	+2.26%
2017-12-31	₩6.28 Billion ≈ $4.26 Million	-1.51%
2016-12-31	₩6.38 Billion ≈ $4.32 Million	+2.67%
2015-12-31	₩6.21 Billion ≈ $4.21 Million	+18.44%
2014-12-31	₩5.24 Billion ≈ $3.55 Million	+43.75%
2013-12-31	₩3.65 Billion ≈ $2.47 Million	-6.06%
2012-12-31	₩3.88 Billion ≈ $2.63 Million	-22.03%
2011-12-31	₩4.98 Billion ≈ $3.37 Million	--

About Cell Biotech Co. Ltd

KQ:049960 Korea Biotechnology & Medical Research

Market Cap

$79.89 Million

₩117.88 Billion KRW

Market Cap Rank

#19986 Global

#1013 in Korea

Share Price

₩15270.00

Change (1 day)

+0.20%

52-Week Range

₩11500.00 - ₩18110.00

All Time High

₩56579.38